Features of Diabetic Neuropathy in COVID-19. Potential of Polypeptide Therapy as Prevention and Concomitant Treatment
Duration: 36 acad. hrs
Form of study: Distance learning (part-time, without interruption from work) using distance educational technologies
Issued document: Advanced Training Certificate
Price: 5,500 RUB
Program Objectives
The objective of this supplementary professional continuing education program is the systematization and deepening of professional knowledge on the pathogenetic features of diabetic neuropathy in the setting of COVID-19. The curriculum explores the clinical potential of polypeptide therapy as both preventive and concomitant treatment for neurological complications in patients with diabetes mellitus.
Competencies Enhanced Upon Program Completion
Upon completing this program, the student enhances the following professional competency: readiness and ability to diagnose, manage, and prevent diabetic neuropathy in post-COVID-19 patients, utilizing modern biomedical and polypeptide therapies.
Knowledge Acquired During Training
Theoretical and Clinical Knowledge:
- Pathogenesis of microvascular and neural damage in diabetes mellitus exacerbated by SARS-CoV-2 infection;
- Mechanism of action of peptide bioregulators and polypeptide preparations in peripheral nerve regeneration;
- Diagnostic criteria and staging of diabetic sensorimotor and autonomic neuropathy;
- Comprehensive clinical protocols integrating metabolic control and peptide therapy.
Clinical Skills:
- Performing focused neurological examinations and sensory testing in diabetic patients;
- Selecting personalized peptide therapy dosages and administration routes;
- Monitoring therapeutic response and safety profile during combined pharmacotherapy.
Eligible Specialties for CME Credits
Endocrinology; Internal Medicine; General Medical Practice (Family Medicine); Neurology; Cardiology
Admission Requirements for CME Credits
- Higher medical education degree
- Valid specialist certification or accreditation
- Registration on the CME portal (edu.rosminzdrav.ru)
Form of Final Assessment
Final assessment is conducted as a multiple-choice test consisting of 15 questions.
To successfully pass the assessment, at least 11 correct answers (out of 15) are required.
